Section Editors

Martin R Farlow, MD - Professor of Neurology and Vice-Chairman of Research, Department of Neurology, Indiana University School of Medicine, Indianapolis

Martin R Farlow, MD

Professor of Neurology and Vice-Chairman of Research, Department of Neurology, Indiana University School of Medicine, Indianapolis

Dr Farlow is Professor of Neurology and Vice-Chairman of Research in the Department of Neurology at the Indiana University School of Medicine in Indianapolis. He is also Associate Co-Director of the Indiana Alzheimer’s Disease Center in Indianapolis and leads a large Alzheimer and related dementias clinical trials site in the Department of Neurology and has lead and/or contributed in various ways to over 150 clinical trials over the last 25 years. Dr Farlow received his medical degree from Indiana University School of Medicine and completed an internship in medicine and residency in neurology at the Indiana University Hospitals. Dr Farlow is a member of many professional associations including AAN, ANA and AGS. He is also a founding member in both the American Society of Experimental Neurotherapeutics and the International Society for CNS Clinical Trials and Methodology. Dr Farlow has lectured on the topics of aging, dementia, and Alzheimer’s disease at more than 300 meetings, conferences, and hospitals/medical schools throughout the world. He is a reviewer for numerous scientific journals and on the editorial boards of MedLink and Current Alzheimer Research. A prolific author, Dr Farlow has presented more than 467 abstracts at professional meetings and has authored or co-authored more than 455 articles published in peer-reviewed journals such as Lancet Neurology, Annals of Family Medicine, and Journal of the American Geriatrics Society. Dr Farlow’s research focuses on clinical trials of investigational drugs for the treatment of Alzheimer’s disease and related dementias being the lead investigator for several major studies including; tacrine, donepezil, rivastigmine, CAD106, solanezumab and has interests in trial design and safety. Dr Farlow also has clinically characterized and helped determine genetic linkage for several familial dementias including the second mutation associated with autosomal dominantly inherited Alzheimer’s disease, Gerstmann-Straussler- Scheinker disease and Multi Systems Tauopathy with Dementia.

Bengt Winblad - MD, PhD, Professor of Geriatrics and Head of the Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet

Bengt Winblad

MD, PhD, Professor of Geriatrics and Head of the Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet

Roger Bullock - Director, Roger Bullock Consulting/Kingshill Research Centre, Swindon

Roger Bullock

Director, Roger Bullock Consulting/Kingshill Research Centre, Swindon

Latest Articles

Latest Videos

Video List based on Category on Node Page

Latest Videos

Sean Knox talks to us about the aims of the Innovative Medicines Initiative – European Prevention of Alzheimer’s Dementia Consortium (IMI-EPAD), progress to date and where further information can be found on this important project. Visit EPAD here. Speaker disclosures: Full time employee of Novartis Pharma AG, a consortium partner of IMI-EPAD. Filmed at the 3rd Congress of the European...
Prof. Martin Farlow, esteemed member of the US Neurology Editorial Board, discusses the use of antipsychotics in adults with dementia, and the benefit of tau imaging in the diagnosis of Alzheimers. Part 2 of 2. View part 1 here. Filmed at the American Academy of Neurology (AAN) Annual Meeting, Boston, US, April 2017
Prof. Martin Farlow, esteemed member of the US Neurology Editorial Board, discusses the recent clinical trial of solanezumab in Alzheimer's disease and the current treatment landscape. Part 1 of 2. View part 2 here. Filmed at the American Academy of Neurology (AAN) Annual Meeting, Boston, US, April 2017